Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial

Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.
    Difference
    0.9%
    Check dated 2025-07-04T01:19:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been changed from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-19T17:25:10.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:42:38.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T04:55:55.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T18:07:00.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a Phase 1 study comparing subcutaneous and intravenous formulations of CT-P13 for treating Crohn's Disease and Ulcerative Colitis. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    15%
    Check dated 2025-04-16T13:07:41.000Z thumbnail image

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.